...
首页> 外文期刊>Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology >Myocardial perfusion imaging to guide percutaneous revascularization of chronic total occlusions: A gate keeper to the final frontier in PCI
【24h】

Myocardial perfusion imaging to guide percutaneous revascularization of chronic total occlusions: A gate keeper to the final frontier in PCI

机译:心肌灌注成像引导慢性总闭塞的经皮血运重建:PCI中最终前沿的栅极保持器

获取原文
获取原文并翻译 | 示例
           

摘要

Percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) is experiencing a renaissance due to novel equipment and techniques resulting in enhanced safety and rising success rates from 50% to the range of 80%-90%. This progress has challenged the prevailing therapeutic dogma of treating CTOs predominantly with either stand alone medical therapy or coronary bypass surgery (CABG) when there is sufficient global disease burden. In fact, in an era of appropriate use criteria the presence of a CTO can be significant determinant for referral for CABG. However, with lesion-specific physiologic assessment, a significant portion of non-CTO lesions in multi-vessel disease patients with CTOs are found to be non-hemo-dynamically significant, reducing the territories requiring revascularization and thus expanding percutaneous therapeutic options.
机译:慢性总闭塞(CTO)的经皮冠状动脉干预(PCI)正在经历由于新颖的设备和技术而导致的安全性,并且成功率增加到80%-90%的成功率。 这一进展挑战了主要的治疗性教条,其主要用途单独治疗CTO治疗,无论是单独的医疗治疗还是冠状动脉旁路手术(CABG),当存在足够的全球性疾病负担时。 事实上,在适当使用标准的时代,CTO的存在对于CABG来说,CTO的存在可能是重要的决定因素。 然而,通过病变特异性的生理评估,发现CTO的多血管病患者的非CTO病变中的大部分非CTO病变是非血腥动态的,减少了需要血运重建的领土,从而扩大经皮治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号